Join the club for FREE to access the whole archive and other member benefits.
Key points from article :
CRISPR used to correct mutated hematopoietic stem cells.
Corrected blood stem cells produced healthy hemoglobin.
Engineered stem cells remained in circulation for at least four months.
Safety analyses needed before human trials.
The study was published in the Science Translational Medicine journal.
Click on resource name for more details.
Biomedical research institute affiliated with California's pediatric medical center.
Journal that publish papers with topics related to translational medicine
